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The Risk of Chromosomal 
Abnormalities in Cases of Minor 




Currently, noninvasive intrauterine screening for most chromosome abnormalities 
is available, but ultrasound examinations also play an important role during preg-
nancy, by drawing the attention to the suspect of a possible abnormality. Fetal ultra-
sound disorders can be classified into two major groups: (1) Major abnormalities are 
actually diagnosed malformations that are often associated with certain chromosome 
abnormalities but may be associated with other disorders (multiplex malformation) 
and may occur as isolated disorders (e.g., cardiac disorders, duodenal atresia, ompha-
locele, cystic hygroma (CH)). (2) Minor anomalies (“soft markers”) are not abnormal 
in themselves but are mild abnormalities that may occur in normal pregnancy but 
also increase the risk of certain chromosome aberrations. The minor anomalies in 
the second trimester include thickened nuchal fold (NF), mild ventriculomegaly, 
pyelectasis, hyperechogenic bowels, hyperechogenic papillary muscle, and shorter 
long bones. Plexus choroid cyst which is classified as a minor marker does not increase 
the risk of Down syndrome but increases the risk of trisomy 18 (Edwards syndrome). 
We want to emphasize the importance of screening of minor and major ultrasound 
abnormalities in detecting chromosomal abnormalities in the second trimester.
Keywords: obstetric genetics, prenatal diagnosis, chromosomal abnormalities, 
prenatal ultrasound, fetal anomalies
1. Introduction
The chromosomal abnormalities account for a considerable part of the anoma-
lies of the intrauterine fetus. Chromosomal abnormalities are the numerical (aneu-
ploidies) and structural anomalies, which can be demonstrated by special methods 
of examination. The numerical and structural anomalies can be duplications/triso-
mies, deletions/monosomies, and other rearrangements on the chromosomes.
The autosomal trisomies and unbalanced rearrangements might cause severe 
multiple malformation syndromes and mental retardation. The rate of the intra-
uterine deaths is high. They cause mainly severe diseases; in some cases they are 
associated with anomalies which are incompatible with the postnatal life.
Besides the age, a history of aneuploidy, and noninvasive tests, positive ultra-
sound findings—which could be major structural abnormalities or minor ultra-
sound markers—can be an indicator for chromosome analysis [1].
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2. Abnormalities with subcutaneous edema
As the first-trimester nuchal edemas (nuchal translucency, NT), the second-tri-
mester nuchal edemas (nuchal thickening, nuchal fold, NF) also elevate the risk of 
chromosome abnormalities. It is important to distinguish nuchal edema and cystic 
hygroma (CH), and in the case of nonimmune hydrops (NH), it is also important to 
discuss cases with or without cystic hygroma separately.
Abnormalities with subcutaneous edema (nonimmune hydrops (NH), cystic 
hygroma, nuchal edema) increase the risk of chromosome abnormalities. They may 
warn of a possible intrauterine infection; in the case of nonimmune hydrops, for 
example, parvovirus B19 infection may occur. They may also be indicative of other 
pathologies accompanied with fetal anemia, including thalassemia, twin-to-twin 
transfusion, and disorders of fetal circulation and abnormal anatomy of the fetal 
heart.
2.1 Nuchal fold (nuchal thickening) in the second trimester
In the second trimester, we examine the thickened nuchal fold (nuchal thicken-
ing, NF) in the horizontal section, level with the cerebellum and also containing 
the cavum septum pellucidum and the cisterna magna. This method, in contrast 
to the one used in the first trimester, measures the thickness of the soft tissue 
from the external aspect of the skin to the external aspect of the bone. Authors 
suggest 5 mm as a cutoff value [2, 3]. A large nuchal translucency detected in the 
first trimester is a non-specific malformation, and in most cases it resolves during 
the second trimester of the pregnancy, although it might persist in certain cases 
to show a picture of nuchal thickening. It indicates an increased risk of trisomy 21 
(Down syndrome) [4].
Benacerraf et al. were the first in drawing the attention to the fact that the 
nuchal fold or nuchal thickening (≥6 mm) observed during the ultrasound exami-
nation in the second trimester increases the risk of Down syndrome [4].
Numerous authors carried out similar examinations, subsequently demonstrat-
ing different results. Gray and Crane [3] tried to determine the proper cutoff 
values of nuchal thickening. They formulated two groups according to the size of 
the pregnancy, putting the values measured in weeks 14–18 to the first group and 
the data of weeks 19–24 to the second group. Considering the examinations, the 
suggested cutoff value in the first group (weeks 14–18) is ≥5 mm, and in the second 
group (weeks 19–24), it is ≥6 mm [5]. In their investigations, Gray and Crane [3] 
detected pathological karyotypes in 12 out of 47 cases (25.53%). Analyzing 23 cases, 
DeVore and Alfi found pathological karyotypes in 9 cases (39.13%) [6].
Other authors detected pathological karyotypes in 10% of second-trimester 
nuchal edema. Grandjean and Sarramon [7] processed the data of 3308 ultrasound 
examinations, with the help of 12 centers, and they found nuchal thickening in 38% 
of the cases of trisomy 21. According to the records of 12 centers, they performed 
karyotyping of 295 pregnancies in the second trimester with nuchal thickening. 
They found abnormal chromosomes in 22 cases (7.46%), 17 of these were trisomy 21 
(5.76%) [7]. Gonen et al. [8] carried out karyotyping in 573 cases because of posi-
tive ultrasound findings during ultrasound examinations in the second trimester. 
There were 38 chromosome analyses carried out due to nuchal thickenings; in one 
case they found an abnormal karyotype (2.63%) [8]. Zimmer et al. discussed their 
cases of early second-trimester nuchal edema in 43 out of 1254 cases (3.43%); they 
detected pathological karyotypes, trisomy 21 being the chief cause in 27 cases, while 
other pathological karyotypes were blamed in 16 cases [9].
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Beke et al. [10] showed a value within 10% in the case of nuchal fold (thick-
ening) measured in the second trimester. A total of 254 cases of chromosomal 
examination was performed for second-trimester nuchal edema, and in 14 cases, 
an abnormal karyotype was detected (5.51%). With the highest frequency, mono-
somy X occurred (nine cases, 3.54%), while in three cases trisomy 21, in 1-1 cases 
trisomy 18 (Edwards syndrome), and another chromosome abnormality were 
detected [10].
2.2 Cystic hygroma
Cystic hygroma is observable in the first and second trimesters. It can be dif-
ferentiated from nuchal translucency and nuchal thickening by the clearly isolated 
fluid space and the typical medial line septation shown on ultrasound examination 
[11, 12]. Cystic hygroma often persists and is often associated with aneuploidy 
(mainly monosomy X), other abnormalities, and fetal loss [12].
In the case of cystic hygroma, the risk of the chromosome abnormality is even 
higher than in cases of nuchal thickening. Bronshtein et al. found chromosome 
anomalies in 6 of 106 nonseptated cases (5.66%), whereas the risk of the chromo-
some abnormality in the 25 septated cases was 72% [12].
Nadel et al. [13] examined in separate groups those cases where the cystic 
hygroma occurred by itself (isolated) and those where it was a part of the hydrops 
phenomenon. In cases of individually occurring 26 hygromas, there were chromo-
some abnormalities in 12 cases (46.15%), while in hydrops-associated cases (37 
cases), they found 31 chromosome anomalies (83.78%) [13]. Due to cystic hygroma, 
Gonen et al. detected 15 cases of pathological (abnormal) karyotype in 182 cases 
(8.24%) [8]. Sohn and Gast [14] found 20 cases of abnormal karyotype of the 
57 cystic hygroma cases (35.09%). There were 11 cases of monosomy X (Turner 
syndrome), 5 cases of trisomy 21, and 4 cases of trisomy 18 [14]. Taipale et al. 
carried out karyotyping in 76 cases of cystic hygroma, and they found chromosome 
abnormalities in 18 cases (23.68%), monosomy X in 5 cases, trisomy 21 in 7 cases, 
and trisomy 13 (Patau syndrome) and trisomy 18 in 6 cases [15].
Beke et al. [10] had a similar result. In terms of isolated cystic hygroma, fetal 
chromosome examinations were performed in 27 cases, and in 13 cases abnormal 
karyotypes were detected (48.15%). When cystic hygroma was associated with 
hydrops, a total of 13 cases was investigated, and 7 cases of chromosomal abnor-
malities (53.85%) were detected [10].
In the first and early second trimesters, Rosati and Guariglia [16] examined 
the volume of cystic hygromas by volumetric calculations. They also analyzed 
the proportion of associated chromosomal abnormalities, and in 8 of 14 septated 
cases, they detected pathological karyotypes (57.14%), whereas four pathologi-
cal karyotypes (21.05%) were seen in the 19 nonseptated cases. In summary, the 
12 patients with chromosomal abnormalities (36.36%) were divided as follows: 
trisomy 21 in 6 patients, monosomy X in 4 cases, and trisomy 18 and 13 in 1 case 
each [16]. Examining the septated and nonseptated cases together, Tanriverdi et al. 
found 13 pathological karyotypes (56.52%) among the 23 karyotyped patients [17]. 
Donnenfeld et al. applied karyotyping and fluorescent in situ hybridization (FISH) 
in the chromosomal investigation of the cells in the sample obtained from the fluid 
of the cystic hygroma and could justify monosomy X in 86% [18].
Examining a total of 218 fetuses with subcutaneous edema, Gezer et al. [19] 
found that nuchal fold, cystic hygroma, and nonimmune hydrops could be 
significant markers for abnormal chromosome numbers. Of these 218 cases, 71 
(32.57%) were diagnosed with abnormal karyotype. The percentage breakdown 
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in 71 cases was as follows: 37% monosomy X, 44% trisomy 21, 15% trisomy 18, 
and 4% trisomy 13 [19].
2.3 Nonimmune hydrops
Similarly to cystic hygroma, nonimmune hydrops can be observed both in the 
first and second trimesters and is often associated with aneuploidy (monosomy X 
or trisomy 21) and fetal loss [13].
Nicolaides et al. studied 37 cases in 1986 and demonstrated 12 cases of chromo-
some anomalies (32.43%) [20]. Gembruch et al. found 17 abnormal karyotypes 
examining 45 hydrops cases (37.78%), 10 cases of monosomy X (1 mosaic form), 6 
cases of trisomy 21, and 1 case of trisomy 18 [21].
Boyd and Keeling [22] and Anandakumar et al. [23] found X-monosomies in 
50% of the demonstrated chromosome abnormalities. Boyd and Keeling [22] found 
11 X-monosomies of the 22 cases of chromosome anomalies of the 72 nonimmune 
hydrops cases (30.56%), while Anandakumar et al. [23] carried out karyotyping in 
cases of 100 hydrops-affected fetuses and demonstrated 5 cases of X-monosomies 
of 10 abnormal cases (10%).
Schwanitz et al. examined in separate groups the nonimmune hydrops cases 
associated with cystic hygroma and the individually occurring ones. When it 
was associated with cystic hygroma, abnormal karyotypes were demonstrated in 
54.39%; without cystic hygroma this rate was 27.69% [24].
Has carried out investigations into nonimmune hydrops in the first trimester 
and found 9 pathological karyotypes (47.37%) out of 19 cases [25].
In the case of nonimmune hydrops, Beke et al. found chromosomal abnormali-
ties in 4 out of 20 cases (20%), in each case monosomy X [10].
3. Cerebral and cranial anomalies
In the case of ventriculomegaly, a greater than normal amount of liquor expands 
the ventricular system. Cerebrospinal fluid may be overproduced, impaired, or 
obstructed. Increased pressure leads to thinning of the brain, creating hydrocepha-
lus internus. Hydrocephalus externus is referred to as the proliferation of liquor in 
the subarachnoid space. Ultrasound first shows the expansion of the posterior horn 
of the side chamber. In cases of choroid plexus cyst and other cranial malforma-
tions, the risk of chromosomal abnormalities is also elevated.
3.1 Ventriculomegaly
In cases of cerebral anomalies, we define ventricular dilatation (ventriculomeg-
aly) as a lateral ventricle with a diameter ≥ 10 mm. The ventricle of normal male 
fetuses is mildly wider (average 6.4 mm) than of the ventricle of normal female 
fetuses (average 5.8 mm) [26]. Ventriculomegaly increases the incidence rate of 
aneuploidy (trisomy 21 and other aneuploidies) [27, 28].
Several authors were examining ventriculomegaly as one possible marker of the 
fetal chromosome abnormalities in the second trimester. Nicolaides et al. carried 
out karyotyping in 9 cases because of fetal ventriculomegaly, examining this among 
other anomalies, and they found chromosome abnormalities in 2 cases (22.22%) 
[20]. Following this, Mahony et al. [28] found 1 case of 20 ventriculomegalies 
(5%); Bromley et al. [27] observed 5 cases of chromosome anomalies examining 
44 cases of ventriculomegaly (11.36%). The study of Gonen et al. [8] also extended 
to more anomalies; as a part of it, they carried out karyotyping in 25 cases of 
5The Risk of Chromosomal Abnormalities in Cases of Minor and Major Fetal Anomalies…
DOI: http://dx.doi.org/10.5772/intechopen.88271
ventriculomegalies and found no abnormal karyotypes. Terry et al. [29] detected 
abnormal chromosomes in 3 cases of the 25 examined fetuses (12%).
Beke et al. [30] found different karyotypes in 26 (6.25%) out of the 416 exam-
ined fetuses. If ventriculomegaly was isolated (191 cases), the rate of the chromo-
some abnormality was 3.7% (7 cases). In four cases, trisomy 21 was detected, in two 
cases monosomy X, and in one case trisomy 18. Lateral ventricular dilation (ven-
triculomegaly) was associated with other ultrasound findings in 225 cases, and in 19 
of these, there were chromosome abnormalities detected (8.4%). The distribution 
of pathological (abnormal) karyotypes was as follows: 4-4 cases of monosomy X 
and 47, XXY karyotype (Klinefelter syndrome), 3-3 cases of trisomy 21 and trisomy 
18, and 1-1 case of trisomy 13, 47,XXX, 47,XYY, 49,XXXY karyotypes and triploidy 
were detected. We found a higher rate in cases of bilateral anomaly (ventriculo-
megaly) (8.6%) than in unilateral cases (4.6%) [30].
3.2 Choroid plexus cysts
According to the data of more authors, the choroid plexus cysts (CPC) mainly 
increase the risk for trisomy 18 [31, 32]. According to certain studies, the risk level 
does not depend on whether the anomaly is unilateral or bilateral, but other studies 
show that the larger the anomaly (>10 mm), the higher the risk [33, 34]. Certain 
authors suggest the 2–2.5 mm cutoff value [35], while others determined the 5 mm 
limiting value [33]. The cysts resolve practically every time, so the absence of the 
anomaly on a repeated ultrasound examination does not indicate a decrease in the 
risk [36].
Chudleigh et al. were the first who described cysts in the fetal choroid plexus 
[37]. Nicolaides et al. were the first who drew attention to the connection between 
the positive ultrasound finding of choroid plexus cysts and chromosome abnor-
malities, through a study including a small number of cases [20]. Thereafter, more 
authors demonstrated that fetal choroid plexus cysts mainly increase the risk of 
trisomy 18 and, to a lesser degree, the risk of trisomy 21.
Achiron et al. demonstrated 2 trisomy 18 cases from chromosome analysis of 30 
CPC cases (6.67%); in 1 case the CPC was associated with other ultrasound anoma-
lies [38]. Platt et al. found 4 cases of chromosome abnormalities from 62 cases 
(6.45%), in 3 cases it was trisomy 18, and in 1 case it was trisomy 21 [39]. Nadel et al. 
demonstrated 12 cases (5.13%) of abnormal chromosomes from a larger number of 
cases (234 cases), 11 of which were trisomy 18 (4.7%) and 1 case of triploidy, but 
from 234 cases there were 220 cases of isolated CPC, and in these cases they did not 
detect any chromosome abnormalities [40].
Walkinshaw et al. demonstrated 4 cases (2.63%) of chromosome anomalies out 
of 152 isolated CPC cases, 3 cases trisomy 18 (1.97%) and 1 case trisomy 21 [33]. 
Nava et al. found eight chromosome abnormalities in 176 cases (4.55%), 4 cases of 
trisomy 18 (2.27%), 2 cases of trisomy 21 (1.14%), 1 case of 47, XXY karyotype, and 
1 case of another chromosome anomaly [41]. From the trisomy 18 cases, there was 
one case of isolated choroid plexus cyst, while in three cases the abnormality was 
associated with other ultrasound findings. Gonen et al. in 1995 demonstrated no 
abnormalities in the course of intrauterine karyotyping of 108 CPC cases [8].
Gray et al. performed karyotyping in 208 cases, and they detected abnormal 
karyotypes in 7 cases; each case was trisomy 18 (3.37%) [34]. Bakos et al. found 3 
abnormal karyotypes out of 108 examined cases (2.78), 1 case was trisomy 18, and 1 
case was trisomy 13 and one inversion of chromosome 9 [42].
Chitty et al. [43] with a larger number of cases found chromosome abnormali-
ties in 14 cases (2.13%). They examined separately the isolated cases and the cases 
associated with other ultrasound anomalies. In 603 cases, the choroid plexus cyst 
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was not associated with other ultrasound abnormalities, and in 3 cases (0.5%), they 
found abnormal karyotypes (each was trisomy 18); in 55 cases the abnormality was 
associated with other ultrasound findings, and in 11 cases (20%), they detected 
abnormal karyotypes (in 9 cases trisomy 18, in one case trisomy 21, and in 1 case 
47,XXX karyotype) [43]. With a similarly large number of cases, Ghidini et al. 
examined the incidence of chromosome abnormalities in cases of choroid plexus 
cysts, they only examined the isolated cases (765 cases), and they found abnormal 
karyotypes (trisomy 18) in 13 cases (1.7%) [44].
Coco et al. [45] in 2004 examined separately the isolated cases and those associ-
ated with other abnormalities, the cases associated with minor and major ultra-
sound anomalies. The rate of abnormal karyotypes was 0.55% in total. In isolated 
cases (311 cases) and in associated cases with minor anomalies (43 cases), they 
did not find any abnormal karyotypes. In the two detected cases of trisomy 18, the 
choroid plexus cyst was associated with major anomalies (16.67% from 12 cases) 
[45]. Sahinoglu et al. [46] performed karyotyping in 109 cases due to choroid plexus 
cyst, 3.67% of the patients had an abnormal karyotype, in 102 cases, it was isolated 
anomaly, and in 3 cases they found chromosome abnormalities (2.94%). In seven 
cases, the choroid plexus cysts were associated with other ultrasound anomalies, 
and they found chromosome abnormality in one case (14.29%); in all the detected 
four cases, the abnormal karyotype was trisomy 18.
According to a 2008 study, of the 435 cases identified by CPC, 390 undertook 
karyotyping. Of these, anomalies were found in 14 fetuses (3.59%), with the 
highest frequency being trisomy 18 (6 cases, 1.54%); in 1 case trisomy 21 (1, 
0.26%) and 1 case trisomy 9 (0.26%) were detected. The incidence of monosomy 
X was 0.77% (3 cases). In one case, 47, XXY karyotype (0.26%) and in two 
cases other chromosomal abnormalities (0.51%) were confirmed (46,XX/46,XY 
and 46,XY/47,XXY/47,XYY mosaicism). Of the cases studied, other ultrasound 
abnormalities associated with the plexus cyst were found in 178 pregnancies, and 
7 abnormal karyotypes were found (3.93%), 5 cases of trisomy 18, and 2 cases of 
monosomy X. Choroid plexus cyst occurred as an isolated anomaly in 212 pregnan-
cies (it was not associated with any other fetal ultrasound findings (anomalies) and/
or poly/oligohydramnios), and 7 chromosome abnormalities (3.3%) were found, 
one of which was trisomy 18, 1 case trisomy 21, 1 case trisomy 9, 1 case monosomy 
X, and 1 case 47,XXY karyotype. The incidence of chromosome abnormalities was 
also similar in the case of unilateral and bilateral CPC; chromosome abnormalities 
were detected in the case of unilateral (3.3%) and in the case of bilateral anomalies 
(3.9%) [47].
3.3 Other cranial and cerebral anomalies
Other cranial and cerebral anomalies (holoprosencephaly, agenesis or dysgen-
esis of the corpus callosum, Dandy-Walker malformation, and cleft lip or palate) 
according to observations increase the risk of chromosome abnormalities, but 
they do not increase the risk of trisomy 21 [48]. A strawberry-shaped head mainly 
increases the risk of trisomy 18 [49].
Benacerraf et al. reported five cases already in 1984, where they found intrauter-
ine cleft lip and palate and holoprosencephaly during the ultrasound examinations, 
and the chromosome analysis verified trisomy 13 in two cases (33.33%) [50].
Both Parant et al. [51] and later Tongsong et al. [52] reported 12 cases where they 
diagnosed intrauterine holoprosencephaly. The karyotyping in Parant et al. [51]’s 
study verified trisomy 13 in four cases (33.33%); in Tongsong et al. [52]’s study, 
there were three cases of trisomies found (25%); in two cases it was trisomy 13 
(16.67%), and in one case it was trisomy 18 (8.33%). Bullen et al. reported in their 
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study (2001) 68 cases of holoprosencephaly, they made karyotyping in 52 cases, 
where they found an abnormal karyotype in 38% (from 20 cases in 15 cases it was 
trisomy 13, in 2 cases trisomy 18, and in 3 cases other chromosome anomalies, from 
which in 2 cases they recognized the deletion of the long arm of chromosome 13) 
[53]. Studying the etiology of the holoprosencephaly, besides the maternal diabetes 
and trisomy 13, there are also monogenic types [54].
In cases of cleft lip and/or palate, Perrotin et al. [55] demonstrated in their study 
that in those cases they examined, there were no chromosome anomalies provided 
the abnormality was isolated (14 cases), and when they detected it together with 
other positive ultrasound findings, the incidence rate of the chromosome abnor-
malities was high. In 26 cases, there were 15 chromosome anomalies (57.69%), in 8 
cases trisomy 13, and in 5 cases trisomy 18 [55].
Aletebi and Fung [56] studied the abnormalities of the fossa posterior region, 
including the enlarged cisterna magna, the Dandy-Walker malformation, and the 
fossa posterior cyst. They found chromosome abnormalities (trisomy 18) in 1 of 15 
cases (6.67%) [56].
Similarly, Beke et al. found in their study that the frequency of chromosome 
abnormalities was similar to other cranial abnormalities; with 44 fetuses being 
examined, they detected chromosome abnormalities in 7 cases (15.91%) [30].
The aim of Nazer Herrera et al. [57] was to estimate the prevalence of holo-
prosencephaly in relation to births. It turned out that this disorder occurred with 
low frequency in Chile, but it was associated with a high proportion of trisomy 13: 
occurring in 10.91% of the cases examined (6 out of 55 cases) [57].
In another study, this anatomical disorder and chromosome abnormalities were 
associated with a high proportion. According to a study in Japan, five out of seven 
holoprosencephaly cases (71.43%) showed the following differences: two children 
with trisomy 18, two children with trisomy 13, and one with 45,X karyotype [58].
4. Cardiac and thoracic abnormalities
The use of fetal echocardiography may further increase the importance of 
second-trimester ultrasound examinations for screening for chromosomal anoma-
lies. This is particularly true in those cases where screening tests were not available 
in the first trimester or the pregnancy was only recognized later.
4.1 Echogenic intracardiac focus
In the fetal heart, the echogenic intracardiac focus is observable in 3–4% of nor-
mal pregnancies [59]; according to some studies, this rate might reach 10% in the 
Asian population [60]. Its incidence, by some authors, increases the risk of trisomy 
21 [61–65] and, according to some studies, trisomy 13 [66]. According to some 
literature data, the risk is higher if the anomaly is observable in both ventricles [61].
Bromley et al. [61, 62] examined in their studies (reported in 1995 and 1998) 
the correlation between the chromosome anomalies and the echogenic intracar-
diac focus detected during the ultrasound examinations. In 1995 they studied 66 
cases and found trisomy 21 in 4 cases (6.06%) [61]. Chromosome abnormalities 
were found in 14 cases (4.83%) with a higher number of cases (290). In 1998, they 
examined 290 pregnancies in two groups and detected chromosome abnormalities 
(mainly trisomy 21) in 6.4% (125 cases) in that group where the maternal age was 
≥35 years, and in the age group under 35 years (165 cases), this rate was 3.64% 
[62]. Winter et al. demonstrated in their similar report 16 cases of trisomy 21 of the 
studied 163 cases (9.28%) [65].
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In a 2005 publication, the echogenic papillary muscle showed abnormal karyo-
type only when it was associated with other anomalies (4.69%), not in isolated 
cases [30].
4.2 Ventricular septal defect and atrioventricular septal defect
Many authors investigated the correlation among the chromosome abnormali-
ties and the ventricular septal defect (VSD) and the atrioventricular septal defect 
(AVSD). In some cases, the authors managed the cases discovered in the second 
trimester or later in pregnancy (third trimester) and the cases diagnosed after birth 
as aggregated data. Hajdu et al. studied 21 cases of AVSD and found chromosome 
anomalies in 9 cases (42.86%); 7 of these were trisomy 21, 1 case trisomy 18, and 1 
case trisomy 22 [67].
Tennstedt et al. [68] analyzed all those cases where the fetopathological exami-
nation verified cardiac malformation, and there were ultrasound examinations and 
karyotyping during the pregnancy (altogether 129 cases). A total of 36 fetuses had 
VSD, and 21 fetuses had AVSD. In cases of VSD, there were 15 fetuses (41.67%) with 
detected chromosome anomalies (8 cases of trisomy 21, 4 cases of trisomy 18, 1 case 
of trisomy 13, 2 cases of other abnormalities). If AVSD occurred, the incidence rate 
of the chromosome anomalies was 61.9% (from 13 cases, 9 trisomy 21 and 3 trisomy 
18, and in 1 case other anomaly) [68]. Delisle et al. [69] studied the incidence of the 
chromosome abnormalities in cases of AVSD detected by ultrasound examinations 
during pregnancy, and from the 38 cases, they found 22 (57.89%) with chromo-
some anomalies (19 cases of trisomy 21, 1 case of trisomy 18, 1 case of trisomy 13, 
and 1 case of other positive finding). Paladini et al. [70] reported a study about 
the risk of chromosome abnormalities in cases of all cardiac (heart and large blood 
vessels) anomalies. In case of ventricular septal defect, the incidence rate of the 
chromosome anomalies was 45.33% (34 of 75 cases), and in case of atrioventricular 
septal defect, this rate was 80% (32 of 40 cases) [70]. From the 34 VSD cases, there 
were 14 cases of trisomy 21 (18.67%), 16 cases of trisomy 18 (21.33%), 2 cases of 
monosomy X (2.67%), and 2 other anomalies detectable. The distribution of the 
32 abnormal karyotypes in case of AVSD was the following: 26 cases of trisomy 21 
(65%), 3 cases of trisomy 18 (7.5%), and 3 other anomalies.
In their work, Beke et al. found abnormalities in 4 out of 18 fetuses with VSD 
(22.22%), including 2 cases of trisomy 18 (11.11%) and 1 case of trisomy 13 (5.56%) 
as well as 1 case of another anomaly [30].
Hajdu et al. [71] later, in 2005 in the case of AVSD, the frequency of the abnor-
mal karyotypes was 66.67%. They studied 39 cases of AVSD and found chromo-
some anomalies in 19 cases (66.67%); 19 of these were trisomy 21, 6 cases trisomy 
18, and 1 case trisomy 22 [71].
A 2006 study dealt with the VSD-related clinical characteristics of the Moroccan 
pediatric population, among others. The 44 patients involved in the research were 
between 2 and 3 years old. Six of them (13.64%) had Down syndrome. VSD patients 
who were later subjected to surgical correction were more likely to be able to avoid 
irreversible pulmonary artery hypertension [72].
According to another, Chinese publication, the association of trisomy 21 is also 
high in the case of complete AVSD (CAVSD). In a group of 35 patients with this type 
of anatomical deviation, Zhong et al. performed chromosome tests in 15 cases. A 
total of 13 chromosome abnormalities (86.67%) have been reported, of which 11 
patients with Down syndrome have been identified [73].
Relatively few studies deal with long-term follow-up of Fallot tetralogy cases. 
According to Shuhaiber et al., the prospects can be positive for those who are being 
treated surgically in the case of the disease. In their study, however, they also refer 
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to the related VSD and the high proportion of trisomy 21 (80.33%, according to 
their calculations) in their combined occurrence [74].
4.3 Other cardiac and large blood vessel abnormalities
In cases of other cardiac abnormalities and anomalies of the large blood vessels, 
the risk of chromosome abnormality is increased [75]. Paladini et al. [70] studied 
the incidence of the chromosome anomalies in cases of other cardiac and large 
blood vessel malformations. In the case of coarctation of the aorta, the incidence 
rate of abnormal chromosomes was 48.28%; in the case of double outlet right ven-
tricle, it was 26.32%; in the case of hypoplastic left heart syndrome, it was 13.51%; 
in the case of truncus arteriosus, it was 33.33%; in the case of Fallot tetralogy, it 
was 45%; and in the case of atrial septal defect, there were no abnormal karyotypes 
found [70].
Other researchers also produced statistics for other heart disorders. 
Chromosome abnormalities were detected in six cases when investigating 33 
fetuses [30].
4.4 Isolated hydrothorax
Only a few authors studied the isolated hydrothorax. Nicolaides carried out 
karyotyping in three cases because of isolated hydrothorax, in connection with an 
invasive intervention (blood gained by fetoscopy) performed due to other positive 
ultrasound findings, and found abnormal karyotype in one case [20]. Estoff et al. 
carried out karyotyping in 11 cases because of isolated hydrothorax, and in 1 case 
they found an abnormal karyotype (trisomy 21, 9.09%) [76]. In other studies, in 
two out of six (33.33%) cases, one case of trisomy 18 (16.67%) and one case of 
monosomy X (16.67%) associations were observed [30].
5. Abnormalities of the abdominal wall and abdomen
In the case of diaphragmatic hernia, abdominal organs appear in the chest due 
to a discontinuity in the compartment. About 90% of the lesion is on the left. The 
aperture of the compartment is not traceable; the abdominal organs of the fetus 
(liver, stomach, and intestines) appear in the chest, which dislocate the mediasti-
num and the heart. Chest space narrowing may lead to severe lung hypoplasia.
In cases of an omphalocele, organs (typically the intestines, stomach, and liver) 
protrude through the opening into the umbilical cord; the opening is in the center 
(median) of the abdominal wall, where the umbilical cord meets the abdomen.
Among the abdominal wall malformations, gastroschisis is a full-thickness 
defect of the abdominal wall, typically to the right of the umbilical cord, not includ-
ing it. Through the open abdominal cavity, the small and large intestines protrude; 
there is no amnioperitoneal membrane covering the exposed organs.
During the ultrasound screening, the “double bubble” is a characteristic sign of 
duodenal atresia. The two “bubbles” are the distended stomach and dilated proxi-
mal duodenum.
Regarding anomalies of the abdominal wall and abdomen, the structural 
malformations associated with chromosome abnormalities are omphalocele and 
duodenal atresia. In cases with echogenic bowel—which is a marker and not neces-
sarily abnormal in itself—the risk of trisomy 21 is higher [77–80]. The etiology 
of echogenic bowel could be other rare abnormalities (cystic fibrosis, atresia) in 




Blancato et al. [82] demonstrated earlier (1992) by in situ hybridization the 
occurrence of tissue-specific mosaicism in some cases of diaphragmatic hernia. 
While during lymphocyte culturing there are no detectable anomalies (blood 
samples via cordocentesis or blood testing of the newborn), in cases of fibroblast 
samples (genetic amniocentesis and dermal biopsy), 12p isochromosome can 
be found. Donnenfeld et al. [83] carried out chromosome analysis in 15 cases of 
diaphragmatic hernia. In all cases they performed lymphocyte culturing (in 14 
cases of fetal cordocentesis) in addition to the fibroblast tests. They found chro-
mosome anomalies in seven cases (46.67%), of which there were three cases of 
trisomy 18, three cases of 12p mosaicism, and one case of other abnormality [83]. 
From the seven cases of anomalies, there were two with different results of the 
cells of different origins due to the mosaicism, and the 12p isochromosome was 
only detectable from the fibroblasts (amniocentesis and dermal biopsy) and not 
from the lymphocytes gained from the blood. In five cases, the examinations of the 
lymphocytes and the fibroblasts gave the same results (three cases of trisomy 18, 
one case of unbalanced translocation, and one case of 12p isochromosome). Huddy 
et al. studied 35 cases of diaphragmatic hernia, they examined the outcome of the 
pregnancy and the related abnormalities, and they found chromosome anomalies in 
4 cases altogether (11.43%), of which 2 were trisomy 18 [84].
5.2 Omphalocele (exomphalos)
Many authors studied the abdominal malformations and the other anomalies 
associated with them. According to all data of the literature, the omphalocele (or 
exomphalos) is associated with chromosome abnormalities in high rates, mainly 
with trisomy 18, and in smaller proportion with trisomy 13.
Mann et al. in their study of obstetrical events associated with abdominal 
malformations reported 7 cases of chromosome abnormalities of 19 cases of 
omphalocele (36.84%) [85]. Rabe et al. processed the results of similar number of 
ultrasonographic screening during pregnancy, and in 17 omphalocele cases, they 
have found 6 chromosome anomalies (35.29%) [86]. Nicolaides et al. in 1986 with 
a smaller number of cases (8 chromosome abnormalities of 12 cases) [20] and later 
Gilbert and Nicolaides in 1987 with 19 chromosome anomalies of 35 cases demon-
strated [87] that the omphalocele detected by ultrasonographic screening increases 
the risk of chromosome abnormalities.
Many other scientists verified the results of these studies. Nyberg et al. [88] 
demonstrated chromosome abnormalities in 10 of 26 cases (38.46%), Holzgreve 
et al. [89] in 5 of 10 cases (50%), Rizzo et al. [90] in 7 of 12 cases (58.33%), and 
Fogel et al. [91] in 5 of 37 cases. In their recent study with a higher number of cases, 
Nicolaides et al. detected abnormal karyotypes in 42 of 116 omphalocele cases 
(36.21%); 32 cases of these were trisomy 18 (27.59%) and in 7 cases trisomy 13 
(6.03%) [92]. Snijders et al. [93] found in higher rate abnormal karyotype, mainly 
trisomy 18, in 12 of 18 cases (66.67%). The following studies demonstrated almost 
the same results, Dillon and Renwick [94] in 12 of 43 cases (27.91%), Axt et al. [95] 
in 7 of 26 cases (26.92%), and Rankin et al. [96] in 30 of 98 cases (30.61%), while 
Stoll et al. [97] have found abnormal karyotypes in 17 cases out of 58 cases (29.31%). 
The majority of the abnormal karyotypes were trisomy 18. Axt et al. found the risk 
of chromosome abnormalities four times higher when the liver was placed intracor-
poreally than when in the extracorporal placement [95]. Barisic et al. [98] processed 
the data of 19 European centers and described 34 abnormal karyotypes in total for 
137 omphalocele cases (24.82%). Most of the chromosomal abnormalities were 
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trisomy 18 (21 cases, 15.33%); they described a lower rate of trisomy 13 (5 cases, 
3.65%), one case of trisomy 21 and monosomy X, two cases of triploidy, and four 
cases of other chromosomal abnormalities. Salihu et al. [99] processed 29 cases, and 
3 abnormal karyotypes were detected (10.34%); in all cases the liver was located 
intracorporeally.
In the study of Beke et al., out of 21 fetuses diagnosed with omphalocele, two 
cases (9.52%) were associated with different karyotypes, 1 case trisomy 18, and 1 
case trisomy 13 [30].
5.3 Gastroschisis
Many investigators studied the gastroschisis cases in parallel with the ompha-
locele screenings, even though some of the studies were carried out with a smaller 
number of cases, so the results are not consistent. Rankin et al. found 1 case of chro-
mosome abnormality in 133 gastroschisis cases (trisomy 13, 0.75%) [96]. Barisic 
et al. [98] also found abnormal karyotypes in 1.89% at a higher number of cases; 
they described chromosomal abnormalities in 2 out of the total 106 cases, of which 
1 was trisomy 21 and the other was trisomy 13.
Other studies with a smaller number of cases did not indicate chromosome 
abnormalities; Mann et al. [85] studied 10 cases, Nicolaides et al. [20, 92] 3 and 26 
cases, Dillon et al. [94] 56 cases, and Axt et al. [95] 18 cases, and they could not 
detect any abnormal karyotype. Stoll et al. [97] studied 47 cases of gastroschisis, 
while Salihu et al. [99] described 15 cases; in these cases there were no abnormal 
karyotypes detected.
Gastroschisis is often associated with other anomalies. Along with polyhy-
dramnios, special attention should be paid to the ultrasound examination of the 
fetus. This was observed by Ozawa et al. [100] in a study involving the analysis of 
52 fetuses. A quarter of them had trisomy (13 cases, 25%), particularly high rates 
of Edwards syndrome detected in 10 cases, while Patau syndrome in 2 cases and 
trisomy 21 in 1 case [100].
In contrast, Stoll et al. [101] diagnosed only one fetus with chromosome abnor-
mality in the case of gastroschisis (trisomy 21) representing 1.16% of the patients 
studied. They also stated that the etiology of omphalocele and gastroschisis is 
unclear and their pathogenesis is controversial [101].
5.4 Duodenal atresia (duodenal obstruction)
The ultrasonographic mark of the duodenal obstruction is the “double bubble.” 
The disease is not always detected intrauterine; therefore some investigators 
involved the subsequently proven, postnatal cases to their study. Studies dem-
onstrated that it mainly increases the risk of trisomy 21. Nicolaides et al. studied 
23 cases and found chromosome abnormalities in 10 cases (43.48%) [92]. Bailey 
et al. detected 15 cases of chromosome anomalies of the 138 cases (trisomy 21) 
(10.87%) [102]. This rate at Heydanus et al. was 7 abnormal karyotypes out of 29 
cases (24.14%), 6 of which were trisomy 21 [103]. Lawrence et al. found 11 cases of 
chromosome anomalies of also 29 cases (37.93%), in 8 cases trisomy 21 [104]. Beke 
et al. found abnormalities in 2 out of 17 studied cases (11.76%), including a trisomy 
21 [30].
5.5 Echogenic bowel
It is controversial in international literature whether the karyotyping is justified 
in cases of echogenic bowel. Nyberg et al. was the first to draw the attention to 
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the echogenic bowel increasing mainly the risk of trisomy 21 [105]. Subsequently 
Scioscia et al. reported 6 cases of chromosome abnormalities of 22 chromosome 
analyses associated with echogenic bowel (27.27%); in 5 cases trisomy 21 and in 1 
case trisomy 18 were found [79]. Bromley et al. carried out 50 karyotyping associ-
ated with echogenic bowel and detected abnormal chromosomes in eight cases 
(16%), six cases of trisomy 21, one case of trisomy 13, and one case of monosomy 
X [77]. Sipes et al. studied seven cases and detected one case (14.3%) of trisomy 18 
[81].
There were two greater studies fully investigating the expectable risk in associa-
tion with echogenic bowel.
Slotnick and Abuhamad [106] separately screened the different measures of 
echogenity in their study published in Lancet, classifying them this way: grade1, 
mild increase of echogenity; grade2, moderate increase; and grade3, pronounced 
increase. They carried out altogether 145 karyotyping because of echogenic bowel 
and found abnormal karyotypes (all trisomy 21) in eight cases (5.5%). There were 
6 cases of trisomy 21 of the 24 grade3 cases (25%), 2 positive cases of the 81 grade2 
cases (2.47%), and no chromosome abnormalities of the 40 cases of grade1. They 
also studied the incidence of cystic fibrosis, they found 5 cases at grade3 and 2 cases 
at grade2, and they did not detect any cystic fibrosis at grade1 [106].
Strocker et al. [80] studied those cases separately, where the increasing bowel 
echogenity was associated with other malformations. They detected abnormal 
karyotypes in 15 cases of altogether 131 cases (11.45%). In 62 cases, the echo-
genic bowel was not associated with other positive ultrasonographic findings; 
in this group, there were 5 chromosome anomalies found, in 4 cases trisomy 
21 (6.45%) and 47, XXY karyotype in 1 case. In the other group, there were 69 
cases associated with other ultrasonographic findings; 10 of these cases carried 
chromosome abnormalities, 8 cases trisomy 21 (11.59), 1 case triploidy, and 1 
case deletion X [80].
According to the observation of Beke et al., chromosome abnormalities were 
detected in only 3 out of 53 cases (5.66%), when the ultrasound image of the echo-
genic bowel was not isolated but associated with other defects [30].
5.6 Other abdominal malformations
Nicolaides et al. [92] also examined other abdominal malformations. In his study 
there were 24 cases of karyotyping due to lack of a visible stomach, and he found an 
abnormal karyotype in 18 cases (75%). In other 24 cases of chromosome analyses 
due to intestinal dilatation, there was 1 with abnormality (4.17%) [92].
6. Pyelectasis
Pyelectasis is the dilatation of only the renal pelvis and the calyces, in milder 
cases, while when the parenchyma is also affected by the longer lasting compression 
(becoming thinner), hydronephrosis develops. Obstructions of the urinary tract 
usually result in the dilatation of the proximal sections. Obstruction of the uretero-
pelvic junction is the main cause of hydronephrosis in the neonates.
According to some authors, an increase in the size of the renal pelvis elevates 
the risk of aneuploidies (mainly trisomy 21) [107–110]. We measure the renal 
pelvis in a horizontal section in the anteroposterior (AP) direction. We define 
renal pelvis dilatation (pyelectasis) as a pelvis with an AP dimension ≥5 mm. 
Hydronephrosis (a renal pelvis ≥10 mm) and enlarged, echogenic kidneys increase 
the risk of trisomy 13.
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Benacerraf et al. [107] studied 210 cases of fetuses with pyelectasis. They found 
trisomy 21 in 7 of the 210 cases (3.33%). The suggested criteria for pyelectasis were 
the following cutoff values, ≥4 mm until week 20 and ≥5 mm in weeks 21–30, and 
after week 30 the limit should be ≥7 mm [107]. Corteville et al. studied 127 cases 
and detected chromosome abnormalities in 7 cases (5.51%), 4 of these were trisomy 
21 (3.15%) [109]. They suggested that until week 33 the cutoff value should be 
≥4 mm; after week 33 this limit would be ≥7 mm. Under comparable conditions 
(121 cases, similar cutoff values), Wickstrom et al. found chromosome anomalies in 
three cases (2.48%), two of which were trisomy 21 (1.65%) [111].
Nicolaides et al. reported in their study 35 abnormal karyotypes that are found 
in cases of 258 fetuses with pyelectasis (13.57%) [92]. Their recommended cutoff 
value was ≥5 mm as a criteria for pyelectasis. Chudleigh et al. carried out chromo-
some analysis using 5 mm cutoff value in 737 cases of fetal pyelectasis. Studying the 
results of the karyotyping, they found abnormal chromosomes in 12 cases (1.63%), 
and 6 of these were trisomy 21 (0.81%) [108]. Besides less number of cases, other 
scientists did not verify the higher rate of chromosome anomalies. Gonen et al. 
found no abnormal karyotypes in 58 cases of fetal pyelectasis [8].
Beke et al. [30] processed 302 cases, of which 7 (2.32%) were found to have 
abnormalities. Of these, 1-1 cases of trisomy 21 and trisomy 18, two cases of mono-
somy X, and three cases of other chromosome abnormalities were found [30].
According to the findings of a 2006 study, contrary to previous opinions that 
male fetuses had a higher rate of chromosome abnormalities associated with pyelec-
tasis, they refuted this. According to this new article by Bronstein et al. [112], there 
is no significant difference between the sexes in the karyotype associated with the 
anatomical disorder. When investigating 672 cases, 35 (5.21%) cases of abnormal 
karyotype occurred [112].
Based on Coco’s and Jeanty [113]’s findings, pyelectasis alone does not justify an 
amniocentesis if it is not associated with anatomical and other abnormalities. However, 
3.01% of their cases were associated with chromosome abnormalities as well [113].
7. Abnormalities of the extremities
Measuring the length of fetal femur and more recently the humerus is part of 
the biometric test. Following the limbs of the fetus, the joints, the hands, and the 
feet and their deviations can be brought into the field of vision. Limb disorders 
may appear independently or as part of syndromes, causing extensive ossification 
anomalies. Most disorders can be rarely recognized prenatally.
7.1 Short femur and humerus
On the basis of several studies of cases with shortened long bones (femur and 
humerus), the incidence rate for the abnormal karyotypes is elevated. According to 
the literature, a shortened humerus is a more sensitive indicator. Mainly the risk of 
trisomy 21 increases [114–117].
Studying the long bones, the main ambition of the investigators was to deter-
mine the proper method to estimate the measure of the retardation in growth, 
which increases the risk of chromosome abnormalities. The two main methods are 
fundamentally different. Some investigators calculate with the observed/expected 
ratio (O/E ratio) and determine the proper cutoff value by expressing the quotient 
in percentile (≤0.91) [8, 115]. Other scientists calculate on the basis of the quotient 
of biparietal diameter (BPD) and femur length (FL) (BPD/FL) and consider 
abnormal the measure of >1.5 SD [114]. Calculating with both methods, most 
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investigators found significant differences between the fetal groups of normal chro-
mosomes and those with chromosome abnormalities. According to some authors, 
the difference was not significant [118, 119].
Nyberg et al. [115] examined separately the parameters (O/E ratio) in the case of 
the humerus and femur and suggested the following cutoff values: humerus ≤0.89 
and femur ≤0.91. If both the femur and the humerus are shortened according to the 
given cutoff values, the risk of trisomy 21 increased 11-fold [115].
Recent studies include both methods. In their report Snijders et al. draw the 
attention to the fact that although they found significant differences using both 
methods (O/E ratio, BPD/FL) between fetal groups of normal karyotype and 
trisomy 21, the screenings before week 18 of gestation are less suitable to predict 
trisomy 21 [116]. Vergani et al. [117] did not find  a significant difference between 
measuring the O/E ratio and using the BPD/FL method; the difference reached the 
significance limit (p = 0.04). According to their report, the measurement of femur 
length is connected with the population, and each center should determine the 
cutoff values dependent on the population on their own [117].
According to a study, chromosome abnormalities occurred in 16% in cases of 
shortened tubular (long) bones, including 8% of trisomy 18 and 4-4% of mono-
somy X and trisomy 21 [30].
A Danish publication processed the data of 2718 fetuses detected with shortened 
femur between the gestational weeks of 17–22, of which 2.5% had chromosome 
abnormalities. In 11 cases, trisomy 21, in 3 cases trisomy 13, and in 8 cases trisomy 18 
were found. Chromosome abnormalities were associated with a higher proportion of 
these anatomical disorders in the second trimester than the first trimester [120].
7.2 Other abnormalities of the extremities
Other malformations of the extremities increase the risk of trisomy 21 (clino-
dactyly, widened pelvic angle, sandal gap), trisomy 13 (postaxial polydactyly, 
clubbed or rocker-bottom feet), and trisomy 18 (clenched hands, overlapping 
digits, radial aplasia, limb shortening, clubbed feet) [48].
8. Conclusions
Ultrasound examinations play an important role during pregnancy, by drawing 
the attention to the suspect of a possible abnormality. The prenatal screening of 
minor ultrasound signs and major ultrasound anomalies and diagnostics is a very 
important part of the health service. The intrauterine screening and diagnostic 
methods, the ultrasound screening during the pregnancy, and the cytogenetic and 
molecular genetic examinations in the genetic centers made the early, intrauterine 
diagnosis of the chromosomal abnormalities possible.
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